US Patent Issued to Genentech on July 29 for "Identification of immunogenic mutant peptides using genomic, transcriptomic and proteomic information" (California Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,372,533, issued on July 29, was assigned to Genentech Inc. (South San Francisco, Calif.).

"Identification of immunogenic mutant peptides using genomic, transcriptomic and proteomic information" was invented by Lelia Delamarre (San Francisco), Patrick Lupardus (San Francisco), Ira Mellman (San Francisco), Mahesh Yadav (San Francisco), Suchit Jhunjhunwala (Sunnyvale, Calif.) and Jennie Lill (Pacifica, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods of identifying a disease-specific immunogenic peptide through a series of selection steps. Immunogenic epitopes identified by methods of the present disclosure are ...